Plain-English translation of NCT07202910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is testing three new imaging measurements—shear wave elastography, shear wave dispersion, and attenuation coefficient imaging—to see if they can accurately diagnose different types of liver disease in children. Instead of requiring a tissue biopsy (which is invasive and uncomfortable), doctors hope these ultrasound-based imaging tools can show what is happening inside the liver safely and non-invasively. The study will involve up to 550 children with various liver conditions, comparing the new imaging results with traditional biopsies and following some children over time to see how well these tools track disease changes.
Currently, diagnosing liver disease in children often requires a biopsy—a procedure where doctors remove a tiny piece of liver tissue—which carries risks and discomfort. This trial exists to develop safer, non-invasive imaging methods that could replace or reduce the need for biopsies while still giving doctors accurate information about what is happening in a child's liver.
You likely qualify if…
You likely don't qualify if…
If your child is in the main study, they will have advanced ultrasound imaging scans performed at the same time they are scheduled for a clinically necessary biopsy, so no extra visits are needed. If your child is in the follow-up study, they will have enhanced ultrasound imaging during their regular appointments for conditions like cystic fibrosis or liver transplant monitoring. Some children may also have an MRI scan if it is medically needed. The scans are painless and non-invasive, similar to a regular ultrasound but with special measurements taken.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Sweden